Humana Reports 9.6% Revenue Growth to $32.4 Billion in Q2 2025

Humana Inc. reported a notable increase in its financial performance for the second quarter of 2025, with total revenues reaching $32.4 billion, a 9.6% increase from $29.5 billion in the same quarter of 2024. The company's net income attributable to Humana was $545 million, or $4.51 per diluted share, compared to $679 million, or $5.62 per diluted share, in the prior year. For the first half of 2025, net income was $1.8 billion, or $14.81 per diluted share, up from $1.4 billion, or $11.74 per diluted share, in the first half of 2024. The year-over-year comparisons were significantly impacted by valuation adjustments related to non-consolidating minority interest investments, impairment charges, and costs associated with value creation initiatives.

The company experienced a 9.1% increase in premiums revenue, totaling $30.7 billion for the second quarter, driven primarily by higher per-member Medicare premiums and growth in state-based contracts. However, services revenue increased by 27.3% to $1.4 billion, largely due to growth in the primary care and pharmacy solutions businesses. Operating expenses also rose, with total operating expenses increasing by 10.2% to $31.3 billion, reflecting higher benefits expenses and operating costs. The benefit ratio for the quarter was 89.7%, up from 89.0% in the previous year, indicating a shift in the business mix towards higher benefit ratio lines.

In terms of strategic developments, Humana has focused on enhancing its integrated care delivery model, which aims to improve health outcomes and affordability for its members. As of June 30, 2025, approximately 3.5 million members, or 68% of individual Medicare Advantage members, were in value-based relationships, a slight decrease from 70% in the previous year. The company also reported a decline in individual Medicare Advantage membership, which decreased by 6.9% year-over-year, while group Medicare Advantage membership increased by 4.6%.

Operationally, Humana's total medical membership decreased to 14.8 million as of June 30, 2025, down from 16.3 million a year earlier. The company noted a significant decline in military services membership, which fell by 23%. Despite these challenges, the company reported growth in its state-based contracts and Medicare stand-alone PDP memberships. The total number of members in specialty services increased by 2.1%, reflecting a stable demand for these offerings.

Looking ahead, Humana anticipates continued growth driven by its strategic initiatives and the ongoing expansion of its healthcare services. The company is committed to enhancing its value creation initiatives, which include cost-saving measures and productivity improvements. However, it also acknowledges potential challenges from regulatory changes and market conditions that could impact its operations and financial performance. The company remains focused on maintaining its competitive position in the healthcare market while navigating these complexities.